Logo
Nazad
N. Houben, S. Fustolo-Gunnink, Karin Fijnvandraat, C. Caram‐Deelder, M. A. Carrascosa, Alain Beuchée, K. Brække, Francesco Cardona, Anne Debeer, Sara Domingues, Stefano Ghirardello, R. Grizelj, Emina Hadžimuratović, Christian Heiring, J. Krivec, Jan Malý, Katarina Matasova, C. Moore, Tobias Muehlbacher, Miklos Szabó, Tomasz Szczapa, G. Zaharie, Justine de Jager, N. J. Reibel-Georgi, Helen V. New, S. Stanworth, E. Deschmann, Charles C. Roehr, Christof Dame, S. le Cessie, J. G. van der Bom, Enrico Lopriore
1 1. 9. 2024.

Red Blood Cell Transfusion in European Neonatal Intensive Care Units, 2022 to 2023

Key Points Question What is the current red blood cell (RBC) transfusion practice for preterm infants born before 32 weeks’ gestation in Europe? Findings This cohort study included 1143 infants from 64 neonatal intensive care units across 22 European countries. By day 28 of life, 36.5% of infants had received an RBC transfusion, and most transfusions based on hemoglobin threshold were given above restrictive thresholds tested in recent trials. Meaning These findings suggest that there is a need to address the gap between evidence and practice and to understand factors influencing ongoing variable practices of RBC transfusions among preterm infants.


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više